Examination of the Pancreas in New-onset Diabetes


About this study

The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Study closed to enrollment

Patient Characteristics:

  • Suspected or definite new-onset diabetes based on recent blood sugar and hemoglobin A1c values
    • HbA1C ≥ 6.5%
  • No acute illness or steroid therapy
  • No prior pancreas surgery

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Gloria Petersen, Ph.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer